Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Journal of Cystic Fibrosis ; 21(Supplement 2):S40, 2022.
Article in English | EMBASE | ID: covidwho-2115168

ABSTRACT

Background: Highly effective modulator therapy and the COVID-19 pandemic have transformed cystic fibrosis (CF) care. Increased use of telehealth has resulted in fewer in-person visits, although close monitoring continues to be crucial in preventing complications. Home spirometry is a useful, accessible tool that people with CF can use to monitor their lung function. In spring 2020, the University of North Carolina (UNC) Adult CF Clinic began to distribute home spirometers to their patients through the Cystic Fibrosis Foundation (CFF). At the time, we lacked a standardized home spirometry program and found it challenging to engage patients in regular use of the device. As a result, the UNC adult CF advanced practice provider (APP) and respiratory therapist (RT) collaborated to lead a quality improvement (QI) project aimed at improving home spirometry at their center. Method(s): Goals of the QI effort were to provide individual education for all patients with a home spirometer, incorporate home spirometry assessments into the RT workflow, and provide monthly interpretation of home spirometry results. The CF RT used Epic MyChart messages to engage patients who needed education and to remind patients to use their device before all visits (virtual or face-to-face). The RT and APP also provided inperson teaching and troubleshooting in clinic, and an educational handout was created. Lastly, one-on-one educationwas provided over the phone on nonclinic days. Between November 2021 and January 2022, people with CF who had received a device and adult CF clinicians were surveyed for anonymous feedback on the program. Survey questions used a 5-point Likert scale to indicate agreement with the survey statement and were adapted from a previous home spirometry survey in lung transplant patients [1]. Result(s): Two hundred sixty-five patients (of 327 total adults with CF at UNC) have received a home spirometer through the CFF or another source;250 of these (94%) have received one-on-one education. All six adult CF clinicians completed the feedback survey. The results indicated a high level of satisfaction and a sense that spirometer use was clinically useful (Figure 1). Seventy-eight patients completed the feedback survey. Regarding the program's utility, respondents agreed or strongly agreed with the following statements: spirometer is easy to use (81%), received adequate training (88%), spirometer is accurate (78%), team is interested in my results (96%), makes me feel secure in detecting problems with my lungs (60%), helpful to share results on the provider dashboard (68%), and am overall satisfied with the home spirometry program (78%). When patients were asked about barriers to use of their home spirometer, 48 (62%) selected "none." The most commonly identified barriers (number of responses)were anxiety (5), too difficult to use (4), too time consuming (3), forgetfulness (3), and accuracy (2).(Figure Presented) Figure 1. Adult cystic fibrosis clinician survey results on home spirometry Conclusion(s):Wewere able to leverage thewidespread availability of home spirometers to create a successful home spirometry program within the UNC adult CF clinic. Our survey results indicate that clinicians and patients felt that home spirometry was useful and were highly satisfied with the program Copyright © 2022, European Cystic Fibrosis Society. All rights reserved

SELECTION OF CITATIONS
SEARCH DETAIL